Sole adjuvant intraoperative breast radiotherapy in Taiwan: a single-center experience

Abstract Introduction Intraoperative radiotherapy (IORT) is more convenient than standard whole breast external beam radiotherapy (EBRT) as a sole adjuvant radiotherapy for breast cancer. The impact of age on breast cancer course and treatment strategy is still under investigation, and the peak age...

Full description

Bibliographic Details
Main Authors: Hsin-Yi Yang, Chi-Wen Tu, Chien-Chin Chen, Cheng-Yen Lee, Yu-Chen Hsu
Format: Article
Language:English
Published: BMC 2021-04-01
Series:Breast Cancer Research
Subjects:
Online Access:https://doi.org/10.1186/s13058-021-01421-y
_version_ 1818566584711512064
author Hsin-Yi Yang
Chi-Wen Tu
Chien-Chin Chen
Cheng-Yen Lee
Yu-Chen Hsu
author_facet Hsin-Yi Yang
Chi-Wen Tu
Chien-Chin Chen
Cheng-Yen Lee
Yu-Chen Hsu
author_sort Hsin-Yi Yang
collection DOAJ
description Abstract Introduction Intraoperative radiotherapy (IORT) is more convenient than standard whole breast external beam radiotherapy (EBRT) as a sole adjuvant radiotherapy for breast cancer. The impact of age on breast cancer course and treatment strategy is still under investigation, and the peak age for breast cancer in Taiwan is much younger than that in Western countries. We aimed to review the oncological outcomes of sole IORT compared with standard EBRT in a country with younger breast cancer patients. Patients and methods We reviewed patients with invasive breast cancer who received breast-conserving surgery (BCS) from September 2014 to December 2016. The clinicopathologic characteristics and oncological outcomes of eligible patients who received EBRT or IORT as sole adjuvant radiotherapy after BCS were collected and reviewed. Results A total of 170 patients were enrolled with a mean follow-up time of 3.53 ± 0.82 years. The risk of locoregional recurrence was 2.44% for EBRT versus 10.64% for IORT (p = 0.024). IORT was a significant risk factor of locoregional recurrence (p = 0.005). The hazard ratios (HRs) for locoregional recurrence in the IORT group compared with the EBRT group were significantly higher in non-suitable risk group patients (HR = 7.02, p = 0.009) and in patients under 50 years old (HR = 10.42, p = 0.011). Conclusions Locoregional recurrence was significantly higher in patients who received IORT than in those who underwent EBRT. IORT should not be used alone in patients under 50 years old who do not belong to a suitable group.
first_indexed 2024-12-14T01:55:36Z
format Article
id doaj.art-538f71f77c3744d8b7f19f6fa77813ba
institution Directory Open Access Journal
issn 1465-542X
language English
last_indexed 2024-12-14T01:55:36Z
publishDate 2021-04-01
publisher BMC
record_format Article
series Breast Cancer Research
spelling doaj.art-538f71f77c3744d8b7f19f6fa77813ba2022-12-21T23:21:12ZengBMCBreast Cancer Research1465-542X2021-04-0123111010.1186/s13058-021-01421-ySole adjuvant intraoperative breast radiotherapy in Taiwan: a single-center experienceHsin-Yi Yang0Chi-Wen Tu1Chien-Chin Chen2Cheng-Yen Lee3Yu-Chen Hsu4Clinical Medicine Research Center, Ditmansion Medical Foundation Chia-Yi Christian HospitalDepartment of Surgery, Ditmansion Medical Foundation Chia-Yi Christian HospitalDepartment of Pathology, Ditmanson Medical Foundation Chia-Yi Christian HospitalDepartment of Radiation Therapy and Oncology, Ditmanson Medical Foundation Chia-Yi Christian HospitalDepartment of Surgery, Ditmansion Medical Foundation Chia-Yi Christian HospitalAbstract Introduction Intraoperative radiotherapy (IORT) is more convenient than standard whole breast external beam radiotherapy (EBRT) as a sole adjuvant radiotherapy for breast cancer. The impact of age on breast cancer course and treatment strategy is still under investigation, and the peak age for breast cancer in Taiwan is much younger than that in Western countries. We aimed to review the oncological outcomes of sole IORT compared with standard EBRT in a country with younger breast cancer patients. Patients and methods We reviewed patients with invasive breast cancer who received breast-conserving surgery (BCS) from September 2014 to December 2016. The clinicopathologic characteristics and oncological outcomes of eligible patients who received EBRT or IORT as sole adjuvant radiotherapy after BCS were collected and reviewed. Results A total of 170 patients were enrolled with a mean follow-up time of 3.53 ± 0.82 years. The risk of locoregional recurrence was 2.44% for EBRT versus 10.64% for IORT (p = 0.024). IORT was a significant risk factor of locoregional recurrence (p = 0.005). The hazard ratios (HRs) for locoregional recurrence in the IORT group compared with the EBRT group were significantly higher in non-suitable risk group patients (HR = 7.02, p = 0.009) and in patients under 50 years old (HR = 10.42, p = 0.011). Conclusions Locoregional recurrence was significantly higher in patients who received IORT than in those who underwent EBRT. IORT should not be used alone in patients under 50 years old who do not belong to a suitable group.https://doi.org/10.1186/s13058-021-01421-yBreast cancerIntraoperative radiotherapyWhole breast external beam radiotherapy
spellingShingle Hsin-Yi Yang
Chi-Wen Tu
Chien-Chin Chen
Cheng-Yen Lee
Yu-Chen Hsu
Sole adjuvant intraoperative breast radiotherapy in Taiwan: a single-center experience
Breast Cancer Research
Breast cancer
Intraoperative radiotherapy
Whole breast external beam radiotherapy
title Sole adjuvant intraoperative breast radiotherapy in Taiwan: a single-center experience
title_full Sole adjuvant intraoperative breast radiotherapy in Taiwan: a single-center experience
title_fullStr Sole adjuvant intraoperative breast radiotherapy in Taiwan: a single-center experience
title_full_unstemmed Sole adjuvant intraoperative breast radiotherapy in Taiwan: a single-center experience
title_short Sole adjuvant intraoperative breast radiotherapy in Taiwan: a single-center experience
title_sort sole adjuvant intraoperative breast radiotherapy in taiwan a single center experience
topic Breast cancer
Intraoperative radiotherapy
Whole breast external beam radiotherapy
url https://doi.org/10.1186/s13058-021-01421-y
work_keys_str_mv AT hsinyiyang soleadjuvantintraoperativebreastradiotherapyintaiwanasinglecenterexperience
AT chiwentu soleadjuvantintraoperativebreastradiotherapyintaiwanasinglecenterexperience
AT chienchinchen soleadjuvantintraoperativebreastradiotherapyintaiwanasinglecenterexperience
AT chengyenlee soleadjuvantintraoperativebreastradiotherapyintaiwanasinglecenterexperience
AT yuchenhsu soleadjuvantintraoperativebreastradiotherapyintaiwanasinglecenterexperience